JNJ Options Signal Bullish Momentum: Focus on $245 Calls and $210 Puts as Volatility Builds

• JNJ surges 1.42% to $244.29, trading above 30D, 100D, and 200D moving averages
• Options market shows heavy call open interest at $245 and $247.50 strikes, with next Friday’s $245 calls (OI: 3,407) as a key focal point
• Block trades hint at institutional positioning in April 2026 options, suggesting long-term conviction

Here’s the takeaway: JNJ’s price action and options data are painting a clear picture of upside potential. The stock is charging toward its Bollinger Band upper limit of $244.55, while call options at the $245 strike dominate open interest. But don’t ignore the shadow of $210 puts—there’s a tug-of-war brewing between bulls and bears.

The Options Imbalance: Where Smart Money Is Betting

Let’s start with the numbers. For this Friday’s expiration, the $245 call (JNJ20260213C245) has 1,039 open contracts—the most of any strike. That’s not random. Think of it as a magnet: if JNJ breaks above $245, those calls could ignite a cascade of profit-taking, pushing the stock higher. Meanwhile, next Friday’s $245 call (JNJ20260220C245) has 3,407 open contracts, nearly triple this week’s volume. That’s a setup for a potential short-term rally.

But here’s the catch: the put side isn’t empty. The $210 put (JNJ20260220P210) has 4,210 open contracts, the largest on the board. If JNJ stumbles below its 200D MA ($182.95) or faces profit-taking, that strike could become a magnet for panic selling. The block trades in April 2026 options (like JNJ20260417C250) add another layer—someone’s hedging or positioning for a summer move.

News That Fuels the Fire

JNJ isn’t just numbers on a screen. Recent headlines are fuel for the bullish run:

• Cardiac tech wins at the 2026 AF Symposium validate JNJ’s R&D pipeline
• A new daily-disposable contact lens expands MedTech’s market grip
• A $1.30 dividend (2.16% yield) rewards patient investors

These aren’t just PR wins—they translate to real demand. The cardiac tech, in particular, could drive institutional buying, especially with puts at $235 (JNJ20260213P235) acting as a near-term floor. But here’s the twist: if the market discounts these innovations as “already priced in,” the RSI at 92.06 warns of overbought conditions. A pullback isn’t out of the question.

Actionable Trade Ideas: Calls, Puts, and Price Levels

For options traders, the JNJ20260213C245 (this Friday’s $245 call) is a high-conviction play. If JNJ closes above $245, the strike could act as a self-fulfilling prophecy. For a longer hold, the JNJ20260220C245 (next Friday’s 3,407 OI contract) offers more time for the stock to rally toward its 200D MA crossover target (~$260).

Bearish players might eye the JNJ20260220P210 (4,210 OI) as insurance against a breakdown. But here’s a pro tip: use the $235 put (JNJ20260213P235) as a tactical hedge if you’re long the stock. For equity traders, consider entry near $240 (current support at 30D MA: $218.19) with a target at $247.50 (next resistance). A stop below $239.68 (today’s low) would protect against a surprise selloff.

Volatility on the Horizon: What to Watch

JNJ’s story isn’t just about today’s 1.42% pop. The block trades in April options and the dividend announcement hint at a stock with both near-term momentum and long-term conviction. The key will be whether the $245 strike becomes a psychological barrier or a launchpad. If bulls hold the 200D MA, this could be the start of a multi-month rally. But if the $210 put (JNJ20260220P210) sees heavy exercise, volatility could spike.

Bottom line: JNJ is at a crossroads. The options market is pricing in a bullish breakout, but the puts at $210 remind us that no trade is without risk. Stay nimble, and let the data guide your next move.